{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:27:34Z","timestamp":1794428854565,"version":"4.9.1"},"publisher-location":"Berlin, Heidelberg","reference-count":149,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642303302","type":"print"},{"value":"9783642303319","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-3-642-30331-9_4","type":"book-chapter","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T10:58:59Z","timestamp":1344941939000},"page":"67-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Coxibs: Pharmacology, Toxicity and Efficacy in Cancer Clinical Trials"],"prefix":"10.1007","author":[{"given":"Luis A.","family":"Garcia Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cea-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Patrignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/CIRCULATIONAHA.105.602425","volume":"113","author":"F Andersohn","year":"2006","unstructured":"Andersohn F, Suissa S, Garbe E (2006) Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 113:1950\u20131957","journal-title":"Circulation"},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.106.181424","volume":"115","author":"EM Antman","year":"2007","unstructured":"Antman EM, Bennett JS, Daugherty A et al (2007) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American heart association. Circulation 115:1634\u20131642","journal-title":"Circulation"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.30175","volume":"63","author":"P Anzellotti","year":"2011","unstructured":"Anzellotti P, Capone ML, Jeyam A et al (2011) Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences. Arthritis Rheum 63:850\u2013859","journal-title":"Arthritis Rheum"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1158\/1055-9965.EPI-08-0167","volume":"17","author":"N Arber","year":"2008","unstructured":"Arber N (2008) Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point. Cancer Epidemiol Biomarkers Prev 17:1852\u20131857","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","volume":"355","author":"N Arber","year":"2006","unstructured":"Arber N, Eagle CJ, Spicak J et al (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355:885\u2013895","journal-title":"N Engl J Med"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCRESAHA.107.165936","volume":"102","author":"E Arehart","year":"2008","unstructured":"Arehart E, Stitham E, Asselbergs FW et al (2008) Acceleration of cardiovascular disease by a dysfunctional prost acyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. Circ Res 102:986\u2013993","journal-title":"Circ Res"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1124\/mol.59.4.901","volume":"59","author":"SJ Baek","year":"2001","unstructured":"Baek SJ, Kim KS, Nixon JB et al (2001) Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59:901\u2013908","journal-title":"Mol Pharmacol"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Baigent C, Blackwell L, Collins R et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849\u20131860","journal-title":"Lancet"},{"key":"4_CR9","unstructured":"Bhatt DL, Scheiman J, Abraham NS et al (2008) ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. In: A report of the American college of cardiology foundation task force on clinical expert consensus documents, vol 52, pp 1502\u20131517"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.STR.0000053029.45352.A0","volume":"34","author":"S Bak","year":"2003","unstructured":"Bak S, Andersen M, Tsiropoulos I et al (2003) Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study. Stroke 34:379\u2013386","journal-title":"Stroke"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1053\/j.gastro.2006.08.079","volume":"131","author":"JA Baron","year":"2006","unstructured":"Baron JA, Sandler RS, Bresalier RS et al (2006) A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131:1674\u20131682","journal-title":"Gastroenterology"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(08)61490-7","volume":"372","author":"JA Baron","year":"2008","unstructured":"Baron JA, Sandler RS, Bresalier RS et al (2008) Cardiovascular events associated with rofecoxib: final analysis of the Approve trial. Lancet 372:1756\u20131764","journal-title":"Lancet"},{"key":"4_CR13","first-page":"57","volume":"6","author":"D Bautista","year":"1997","unstructured":"Bautista D, Obrador A, Moreno V et al (1997) Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 6:57\u201361","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ahj.2008.12.014","volume":"157","author":"MC Becker","year":"2009","unstructured":"Becker MC, Wang TH, Wisniewski L et al (2009) Rationale, design, and governance of prospective randomized evaluation of celecoxib integrated safety versus ibuprofen or naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J 157:606\u2013612","journal-title":"Am Heart J"},{"key":"4_CR15","first-page":"409","volume":"16","author":"A Bennett","year":"1975","unstructured":"Bennett A, Del Tacca M (1975) Proceedings: prostaglandins in human colonic carcinoma. Gut 16:409","journal-title":"Gut"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","volume":"355","author":"MM Bertagnolli","year":"2006","unstructured":"Bertagnolli MM, Eagle CJ, Zauber AG et al (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355:873\u2013884","journal-title":"N Engl J Med"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1194\/jlr.P600014-JLR200","volume":"48","author":"RJ Bisoendial","year":"2007","unstructured":"Bisoendial RJ, Kastelein JJP, Peters SLM et al (2007) Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J Lipid Res 48:952\u2013960","journal-title":"J Lipid Res"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","volume":"343","author":"C Bombardier","year":"2000","unstructured":"Bombardier C, Laine L, Reicin A et al (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR study group. N Engl J Med 343:1520\u20131528","journal-title":"N Engl J Med"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.2174\/138161207781368783","volume":"13","author":"B Boursi","year":"2007","unstructured":"Boursi B, Arber N (2007) Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Curr Pharm Des 13:2274\u20132282","journal-title":"Curr Pharm Des"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H et al (2005) Cardiovascular events associated with rofecoxib in colorectal adenoma. Chemoprevencion trial. N Engl J Med 352:1092\u20131102","journal-title":"N Engl J Med"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1016\/S0002-9343(00)00629-X","volume":"110","author":"J Brun","year":"2001","unstructured":"Brun J, Jones R (2001) Nonsteroidal anti-inflammatory drug-associated dyspepsia: the scale of the problem. Am J Med 110:12S\u201313S","journal-title":"Am J Med"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ccr.2005.12.029","volume":"9","author":"FG Buchanan","year":"2006","unstructured":"Buchanan FG, DuBois RN (2006) Connecting COX-2 and wnt in cancer. Cancer Cell 9:6\u20138","journal-title":"Cancer Cell"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2009.12.008","volume":"105","author":"H Bueno","year":"2010","unstructured":"Bueno H, Bardaj\u00ed A, Patrignani P et al (2010) Spanish case-control study to assess NSAID-associated ACS risk investigators. Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome. Am J Cardiol 105:1102\u20131106","journal-title":"Am J Cardiol"},{"key":"4_CR24","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"A Burke","year":"2006","unstructured":"Burke A, Smyth EM, FitzGerald GA (2006) Analgesic-antipyretic agents; pharmacotherapy of gout. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman and Gilman\u2019s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York","edition":"11"},{"key":"4_CR25","first-page":"18","volume":"20","author":"FG Campos","year":"2005","unstructured":"Campos FG, Logullo Waitzberg AG et al (2005) Diet and colorectal cancer: current evidence for etiology and prevention. Nutr Hosp 20:18\u201325","journal-title":"Nutr Hosp"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","volume":"45","author":"ML Capone","year":"2005","unstructured":"Capone ML, Sciulli MG, Tacconelli S et al (2005) Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. J Am Coll Cardiol 45:1295\u20131301","journal-title":"J Am Coll Cardiol"},{"key":"4_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.prostaglandins.2006.05.019","volume":"82","author":"ML Capone","year":"2007","unstructured":"Capone ML, Tacconelli S, Di Francesco L et al (2007) Pharmacodynamic of cyclooxygenase inhibitors in humans. Prostaglandins Other Lipid Mediat 82:85\u201394","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/01.CIR.0000124715.27937.78","volume":"109","author":"ML Capone","year":"2004","unstructured":"Capone ML, Tacconelli S, Sciulli MG et al (2004) Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Circulation 109:1468\u20131471","journal-title":"Circulation"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","volume":"345","author":"F Catella-Lawson","year":"2001","unstructured":"Catella-Lawson F, Reilly MP, Kapoor SC et al (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809\u20131817","journal-title":"N Engl J Med"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.med.57.121304.131253","volume":"58","author":"YI Cha","year":"2007","unstructured":"Cha YI, DuBois RN (2007) NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58:239\u2013252","journal-title":"Annu Rev Med"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1158\/1940-6207.CAPR-10-0403","volume":"4","author":"AT Chan","year":"2011","unstructured":"Chan AT, Sima SS, Zauber AG (2011) C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res 4:1172\u20131180","journal-title":"Cancer Prev Res"},{"key":"4_CR32","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/STROKEAHA.110.585828","volume":"41","author":"CH Chang","year":"2010","unstructured":"Chang CH, Shau WY, Kuo CW et al (2010) Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study. Stroke 41:1884\u20131890","journal-title":"Stroke"},{"key":"4_CR33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","volume":"344","author":"FK Chan","year":"2001","unstructured":"Chan FK, Chung SC, Suen BY et al (2001) Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 344:967\u2013973","journal-title":"N Engl J Med"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1470-2045(02)00680-0","volume":"3","author":"TA Chan","year":"2002","unstructured":"Chan TA (2002) Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol 3:166\u2013174","journal-title":"Lancet Oncol"},{"key":"4_CR35","doi-asserted-by":"crossref","unstructured":"Cheng I, Caberto CP, Lum-Jones A et al (2011) Type two diabetes risk variants and colorectal cancer risk: the multiethnic cohort and PAGE studies. Gut (May 20 [Epub ahead of print])","DOI":"10.1136\/gut.2011.237727"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/STROKEAHA.107.497040","volume":"39","author":"NK Choi","year":"2008","unstructured":"Choi NK, Park BJ, Jeong SW et al (2008) Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the acute brain bleeding analysis study. Stroke 39:845\u2013849","journal-title":"Stroke"},{"key":"4_CR37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","volume":"235","author":"MA Choti","year":"2002","unstructured":"Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759\u2013766","journal-title":"Ann Surg"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/bmj.327.7427.1322","volume":"327","author":"JP Curtis","year":"2003","unstructured":"Curtis JP, Wang Y, Portnay EL et al (2003) Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study. BMJ 327:1322\u20131323","journal-title":"BMJ"},{"key":"4_CR39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1470-2045(01)00488-0","volume":"2","author":"AJ Dannenberg","year":"2001","unstructured":"Dannenberg AJ, Altorki NK, Boyle JO et al (2001) Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2:544\u2013551","journal-title":"Lancet Oncol"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.CIR.0000085568.13915.1E","volume":"108","author":"H Danenberg","year":"2003","unstructured":"Danenberg H, Szalai A, Swaminathan R et al (2003) Increased thrombosis following injury in human C-reactive protein transgenic mice. Circulation 108:512\u2013515","journal-title":"Circulation"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCRESAHA.108.191114","volume":"104","author":"L Di Francesco","year":"2009","unstructured":"Di Francesco L, Totani L, Dovizio M et al (2009) Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells. Circ Res 104:506\u2013513","journal-title":"Circ Res"},{"key":"4_CR42","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1053\/gast.1996.v110.pm8613017","volume":"110","author":"RN DuBois","year":"1996","unstructured":"DuBois RN, Radhika A, Reddy BS et al (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259\u20131262","journal-title":"Gastroenterology"},{"key":"4_CR43","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","volume":"107","author":"CE Eberhart","year":"1994","unstructured":"Eberhart CE, Coffey RJ, Radhika A et al (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183\u20131188","journal-title":"Gastroenterology"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)16894-3","volume":"364","author":"ME Farkouh","year":"2004","unstructured":"Farkouh ME, Kirshner H, Harrington RA et al (2004) Comparison of lumiracoxib with naproxen and ibuprofen in the therapeutic arthritis research and gastrointestinal event trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 364:675\u2013684","journal-title":"Lancet"},{"key":"4_CR45","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2174\/1381612033454036","volume":"9","author":"A Ferrandez","year":"2003","unstructured":"Ferrandez A, Prescott S, Burt RW (2003) COX-2 and colorectal cancer. Curr Pharm Des 9:2229\u20132251","journal-title":"Curr Pharm Des"},{"key":"4_CR46","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1001\/archinte.164.22.2472","volume":"164","author":"LM Fischer","year":"2004","unstructured":"Fischer LM, Schlienger RG, Matter CM et al (2004) Discontinuation of non-steroidal anti-inflammatory drug therapy and the risk of acute myocardial infarction. Arch Intern Med 164:2472\u20132476","journal-title":"Arch Intern Med"},{"key":"4_CR47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","volume":"345","author":"GA FitzGerald","year":"2001","unstructured":"FitzGerald GA, Patrono C (2001) The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345:433\u2013442","journal-title":"N Engl J Med"},{"key":"4_CR48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJM199901213400301","volume":"340","author":"CS Fuchs","year":"1999","unstructured":"Fuchs CS, Giovannucci EL, Colditz GA et al (1999) Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 340:169\u2013176","journal-title":"N Engl J Med"},{"key":"4_CR49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/003655200750024191","volume":"35","author":"LA Garcia Rodriguez","year":"2000","unstructured":"Garcia Rodriguez LA, Ruigomez A, Wallander MA et al (2000) Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 35:306\u2013311","journal-title":"Scand J Gastroenterol"},{"key":"4_CR50","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1161\/01.CIR.0000132491.96623.04","volume":"109","author":"LA Garc\u00eda Rodr\u00edguez","year":"2004","unstructured":"Garc\u00eda Rodr\u00edguez LA, Varas-Lorenzo C, Maguire A et al (2004) A non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. Circulation 109:3000\u20133006","journal-title":"Circulation"},{"key":"4_CR51","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2008.08.041","volume":"52","author":"LA Garc\u00eda-Rodr\u00edguez","year":"2008","unstructured":"Garc\u00eda-Rodr\u00edguez LA, Tacconelli S, Patrignani P (2008) Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. JACC 52:1628\u20131636","journal-title":"JACC"},{"key":"4_CR52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3748\/wjg.v17.i4.444","volume":"17","author":"O Giouleme","year":"2011","unstructured":"Giouleme O, Diamantidis MD, Marios Katsaros G (2011) Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms. World J Gastroenterol 17:444\u2013448","journal-title":"World J Gastroenterol"},{"key":"4_CR53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0889-8553(02)00057-2","volume":"31","author":"E Giovannucci","year":"2002","unstructured":"Giovannucci E (2002) Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 31:925\u2013943","journal-title":"Gastroenterol Clin North Am"},{"key":"4_CR54","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","volume":"113","author":"GH Gislason","year":"2006","unstructured":"Gislason GH, Jacobsen S, Rasmussen JN et al (2006) Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 113:2906\u20132913","journal-title":"Circulation"},{"key":"4_CR55","first-page":"383","volume":"9","author":"A Goel","year":"2003","unstructured":"Goel A, Chang DK, Ricciardiello L et al (2003) A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 9:383\u2013390","journal-title":"Clin Cancer Res"},{"key":"4_CR56","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1538-7836.2009.03511.x","volume":"7","author":"E Grad","year":"2009","unstructured":"Grad E, Golomb M, Koroukhov N et al (2009) Aspirin reduces the prothrombotic activity of C-reactive protein. J Thromb Haemost 7:1393\u20131400","journal-title":"J Thromb Haemost"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1016\/S0140-6736(05)17864-7","volume":"365","author":"DJ Graham","year":"2005","unstructured":"Graham DJ, Campen D, Hui R et al (2005) Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase two selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365:4996\u20135002","journal-title":"Lancet"},{"key":"4_CR58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199407213310301","volume":"331","author":"ER Greenberg","year":"1994","unstructured":"Greenberg ER, Baron JA, Tosteson TD et al (1994) A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp prevention study group. N Engl J Med 331:141\u2013147","journal-title":"N Engl J Med"},{"key":"4_CR59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","volume":"116","author":"T Grosser","year":"2006","unstructured":"Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116:4\u201315","journal-title":"J Clin Invest"},{"key":"4_CR60","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archinte.168.11.1219","volume":"168","author":"MD Haag","year":"2008","unstructured":"Haag MD, Bos MJ, Hofman A et al (2008) Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke. Arch Intern Med 168:1219\u20131224","journal-title":"Arch Intern Med"},{"key":"4_CR61","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1023\/A:1026130623186","volume":"48","author":"A Hallak","year":"2003","unstructured":"Hallak A, Alon-Baron L, Shamir R et al (2003) Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci 48:1998\u20132002","journal-title":"Dig Dis Sci"},{"key":"4_CR62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<295::AID-PATH254>3.0.CO;2-Y","volume":"187","author":"X Hao","year":"1999","unstructured":"Hao X, Bishop AE, Wallace M et al (1999) Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 187:295\u2013301","journal-title":"J Pathol"},{"key":"4_CR63","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0003-4975(00)02522-4","volume":"71","author":"JR Headrick","year":"2001","unstructured":"Headrick JR, Miller DL, Nagorney DM et al (2001) Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg 71:975\u2013980","journal-title":"Ann Thorac Surg"},{"key":"4_CR64","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehl053","volume":"27","author":"A Helin-Salmivaara","year":"2006","unstructured":"Helin-Salmivaara A, Virtanen A, Vesalainen R et al (2006) NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J 27:1657\u20131663","journal-title":"Eur Heart J"},{"key":"4_CR65","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJM199605023341801","volume":"334","author":"CH Hennekens","year":"1996","unstructured":"Hennekens CH, Buring JE, Manson JE et al (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145\u20131159","journal-title":"N Engl J Med"},{"key":"4_CR66","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.160.14.2093","volume":"160","author":"S Hern\u00e1ndez-D\u00edaz","year":"2000","unstructured":"Hern\u00e1ndez-D\u00edaz S, Garc\u00eda Rodr\u00edguez LA (2000) Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding\/perforation. An overview of epidemiologic studies published in the 1990s. Arch Intern Med 160:2093\u20132099","journal-title":"Arch Intern Med"},{"key":"4_CR67","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1742-7843.2006.pto_302.x","volume":"98","author":"S Hernandez-Diaz","year":"2006","unstructured":"Hernandez-Diaz S, Varas-Lorenzo C, Garcia Rodriguez LA (2006) Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol 98:266\u2013274","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"4_CR68","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","volume":"330","author":"J Hippisley-Cox","year":"2005","unstructured":"Hippisley-Cox J, Coupland C (2005) Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 330:1366\u20131372","journal-title":"BMJ"},{"key":"4_CR69","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM199009203231205","volume":"323","author":"WK Hong","year":"1990","unstructured":"Hong WK, Lippman SM, Itri LM et al (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323:795\u2013801","journal-title":"N Engl J Med"},{"key":"4_CR70","first-page":"1589","volume":"32","author":"M Hudson","year":"2005","unstructured":"Hudson M, Baron M, Rahme E et al (2005) Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction. J Rheumatol 32:1589\u20131593","journal-title":"J Rheumatol"},{"key":"4_CR71","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1572-0241.2002.05528.x","volume":"97","author":"SS Husain","year":"2002","unstructured":"Husain SS, Szabo IL, Tamawski AS (2002) NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol 97:542\u2013553","journal-title":"Am J Gastroenterol"},{"key":"4_CR72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pds.1129","volume":"14","author":"L Ilkhanoff","year":"2005","unstructured":"Ilkhanoff L, Lewis JD, Hennessy S et al (2005) Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI). Pharmacoepidemiol Drug Saf 14:513\u2013522","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4_CR73","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0090-6980(74)80055-9","volume":"6","author":"BM Jaffe","year":"1974","unstructured":"Jaffe BM (1974) Prostaglandins and cancer: an update. Prostaglandins 6:453\u2013461","journal-title":"Prostaglandins"},{"key":"4_CR74","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00018-008-7511-x","volume":"65","author":"NR Jana","year":"2008","unstructured":"Jana NR (2008) NSAIDs and apoptosis. Cell Mol Life Sci 65:1295\u20131301","journal-title":"Cell Mol Life Sci"},{"key":"4_CR75","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJM200006293422606","volume":"342","author":"PA Janne","year":"2000","unstructured":"Janne PA, Mayer RJ (2000) Chemoprevention of colorectal cancer. N Engl J Med 342:1960\u20131968","journal-title":"N Engl J Med"},{"key":"4_CR76","doi-asserted-by":"crossref","unstructured":"Jiang Y, Ben Q, Shen H et al (2011) Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol [Epub ahead of print]","DOI":"10.1007\/s10654-011-9617-y"},{"key":"4_CR77","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.STR.0000054057.11892.5B","volume":"34","author":"SP Johnsen","year":"2003","unstructured":"Johnsen SP, Pedersen L, Friis S et al (2003) Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke 34:387\u2013391","journal-title":"Stroke"},{"key":"4_CR78","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archinte.165.9.978","volume":"165","author":"SP Johnsen","year":"2005","unstructured":"Johnsen SP, Larsson H, Tarone RE et al (2005) Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs. Arch Intern Med 165:978\u2013984","journal-title":"Arch Intern Med"},{"key":"4_CR79","first-page":"2556","volume":"55","author":"SL Kargman","year":"1995","unstructured":"Kargman SL, O\u2019Neill GP, Vickers PJ et al (1995) Expression of prostaglandin G\/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55:2556\u20132559","journal-title":"Cancer Res"},{"key":"4_CR80","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","volume":"332","author":"PM Kearney","year":"2006","unstructured":"Kearney PM, Baigent C, Godwin J et al (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332:1302\u20131308","journal-title":"BMJ"},{"key":"4_CR81","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2003.08.064","volume":"43","author":"SE Kimmel","year":"2004","unstructured":"Kimmel SE, Berlin JA, Reilly M et al (2004) The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin. J Am Coll Cardiol 43:985\u2013990","journal-title":"J Am Coll Cardiol"},{"key":"4_CR82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-142-3-200502010-00005","volume":"142","author":"SE Kimmel","year":"2005","unstructured":"Kimmel SE, Berlin JA, Reilly M et al (2005) Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med 142:157\u2013164","journal-title":"Ann Intern Med"},{"key":"4_CR83","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","volume":"286","author":"MC King","year":"2001","unstructured":"King MC, Wieand S, Hale K et al (2001) National surgical adjuvant breast and bowel project tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: national surgical adjuvant breast and bowel project (NSABP-P1) breast cancer prevention trial. JAMA 286:2251\u20132256","journal-title":"JAMA"},{"key":"4_CR84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.seminoncol.2004.03.041","volume":"3","author":"CH Koehne","year":"2004","unstructured":"Koehne CH, Dubois RN (2004) COX-2 inhibition and colorectal cancer. Semin Oncol 3:12\u201321","journal-title":"Semin Oncol"},{"key":"4_CR85","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.0000087593.07533.9B","volume":"108","author":"T Kurth","year":"2003","unstructured":"Kurth T, Glynn RJ, Walker AM et al (2003) Inhibition of clinical benefits on first myocardial infarction by nonsteroidal anti-inflammatory drugs. Circulation 108:1191\u20131195","journal-title":"Circulation"},{"key":"4_CR86","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","volume":"346","author":"KC Lai","year":"2002","unstructured":"Lai KC, Lam SK, Chu KM et al (2002) Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 346:2033\u20132038","journal-title":"N Engl J Med"},{"key":"4_CR87","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.2001.21907","volume":"120","author":"L Laine","year":"2001","unstructured":"Laine L (2001) Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 120:594\u2013606","journal-title":"Gastroenterology"},{"key":"4_CR88","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","volume":"23","author":"A Lanas","year":"2007","unstructured":"Lanas A, Scheiman J (2007) Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 23:163\u2013173","journal-title":"Curr Med Res Opin"},{"key":"4_CR89","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","volume":"97","author":"S Larsson","year":"2005","unstructured":"Larsson S, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679\u20131687","journal-title":"J Natl Cancer Inst"},{"key":"4_CR90","first-page":"21","volume":"4","author":"S Lev-Ari","year":"2006","unstructured":"Lev-Ari S, Maimon Y, Strier L et al (2006) Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines. J Soc Integr Oncol 4:21\u201326","journal-title":"J Soc Integr Oncol"},{"key":"4_CR91","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-142-7-200504050-00113","volume":"142","author":"LE L\u00e9vesque","year":"2005","unstructured":"L\u00e9vesque LE, Brophy JM, Zhang B (2005) The risk for myocardial infarction with cyclooxygenase-2 inhibitors: A population study of elderly adults. Ann Internal Med 142:481\u2013489","journal-title":"Ann Internal Med"},{"key":"4_CR92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.gastro.2011.03.049","volume":"141","author":"KJ Lin","year":"2011","unstructured":"Lin KJ, Hernandez-Diaz S, Garcia Rodriguez LA (2011) Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology 141:71\u201379","journal-title":"Gastroenterology"},{"key":"4_CR93","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJM198511283132203","volume":"313","author":"M Lipkin","year":"1985","unstructured":"Lipkin M, Newmark H (1985) Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 313:1381\u20131384","journal-title":"N Engl J Med"},{"key":"4_CR94","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0090-6980(82)90123-X","volume":"23","author":"M Livio","year":"1982","unstructured":"Livio M, Del Maschio A, Cerletti C et al (1982) Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins 23:787\u2013796","journal-title":"Prostaglandins"},{"key":"4_CR95","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","volume":"361","author":"TM MacDonald","year":"2003","unstructured":"MacDonald TM, Wei L (2003) Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 361:573\u2013574","journal-title":"Lancet"},{"key":"4_CR96","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archinte.163.4.481","volume":"163","author":"M Mamdani","year":"2003","unstructured":"Mamdani M, Rochon P, Juurlink D et al (2003) Effect of selective cyclooxygenase two inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Arch Intern Med 163:481\u2013486","journal-title":"Arch Intern Med"},{"key":"4_CR97","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/art.27412","volume":"62","author":"EL Mass\u00f3 Gonz\u00e1lez","year":"2010","unstructured":"Mass\u00f3 Gonz\u00e1lez EL, Patrignani P et al (2010) Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 62:1592\u20131601","journal-title":"Arthritis Rheum"},{"key":"4_CR98","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2125.2006.02660.x","volume":"62","author":"P McGettigan","year":"2006","unstructured":"McGettigan P, Han P, Henry D (2006) Cyclooxygenase-2 inhibitors and coronary occlusion: exploring dose-response relationships. Br J Clin Pharmacol 62:358\u2013365","journal-title":"Br J Clin Pharmacol"},{"key":"4_CR99","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","volume":"296","author":"P McGettigan","year":"2006","unstructured":"McGettigan P, Henry D (2006) Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 296:1633\u20131644","journal-title":"JAMA"},{"key":"4_CR100","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","volume":"352","author":"NA Nussmeier","year":"2005","unstructured":"Nussmeier NA, Whelton AA, Brown MT et al (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352:1081\u20131091","journal-title":"N Engl J Med"},{"key":"4_CR101","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1158\/1940-6207.CAPR-11-0333","volume":"4","author":"JA Oates","year":"2011","unstructured":"Oates JA (2011) Cardiovascular risk markers and mechanisms in targeting the COX pathway for colorectal cancer prevention. Cancer Prev Res 4:1145\u20131148","journal-title":"Cancer Prev Res"},{"key":"4_CR102","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.cellsig.2008.02.004","volume":"20","author":"MR Pan","year":"2008","unstructured":"Pan MR, Chang HC, Hung WC (2008) Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras\/c-Raf interaction and activation of MAP kinase phosphatases. Cell Signal 20:1134\u20131141","journal-title":"Cell Signal"},{"key":"4_CR103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3322\/canjclin.49.1.33","volume":"49","author":"DM Parkin","year":"1999","unstructured":"Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49:33\u201364","journal-title":"CA Cancer J Clin"},{"key":"4_CR104","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archinte.164.8.852","volume":"164","author":"TN Patel","year":"2004","unstructured":"Patel TN, Goldberg KC (2004) Use of aspirin and ibuprofen compared with aspirin alone and the risk of myocardial infarction. Arch Intern Med 164:852\u2013856","journal-title":"Arch Intern Med"},{"key":"4_CR105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/hrt.2007.136002","volume":"94","author":"P Patrignani","year":"2008","unstructured":"Patrignani P, Capone ML, Tacconelli S (2008a) NSAIDs and cardiovascular disease. Heart 94:395\u2013397","journal-title":"Heart"},{"key":"4_CR108","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2147\/TCRM.S3209","volume":"4","author":"P Patrignani","year":"2008","unstructured":"Patrignani P, Tacconelli S, Capone ML (2008b) Risk management profile of etoricoxib: an example of personalized medicine. Ther Clin Risk Manage 4:983\u2013997","journal-title":"Ther Clin Risk Manage"},{"key":"4_CR106","first-page":"1705","volume":"271","author":"P Patrignani","year":"1994","unstructured":"Patrignani P, Panara MR, Greco A et al (1994) Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 271:1705\u20131712","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR107","first-page":"661","volume":"50","author":"P Patrignani","year":"1999","unstructured":"Patrignani P, Sciulli MG, Manarini S et al (1999) COX-2 is not involved in thromboxane biosynthesis by activated human platelets. J Physiol Pharmacol 50:661\u2013667","journal-title":"J Physiol Pharmacol"},{"issue":"6 Suppl","key":"4_CR109","doi-asserted-by":"crossref","first-page":"199S","DOI":"10.1378\/chest.08-0672","volume":"133","author":"C Patrono","year":"2008","unstructured":"Patrono C, Baigent C, Hirsh J et al (2008) Antiplatelet drugs: American college of chest physicians evidence-based clinical practice guidelines (8th edn). Chest 133(6 Suppl):199S\u2013233S","journal-title":"Chest"},{"key":"4_CR110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","volume":"17","author":"C Patrono","year":"1980","unstructured":"Patrono C, Ciabattoni G, Pinca E et al (1980) Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res 17:317\u2013327","journal-title":"Thromb Res"},{"key":"4_CR111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1568009043481632","volume":"4","author":"CV Rao","year":"2004","unstructured":"Rao CV, Reddy BS (2004) NSAIDs and chemoprevention. Curr Cancer Drug Targets 4:29\u201342","journal-title":"Curr Cancer Drug Targets"},{"key":"4_CR112","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(02)07370-1","volume":"359","author":"W Ray","year":"2002","unstructured":"Ray W, Stein C, Hall K et al (2002) Non-steroidal anti-inflammatory drugs and the risk of serious coronary heart disease: an observational study. Lancet 359:118\u2013123","journal-title":"Lancet"},{"key":"4_CR113","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCOUTCOMES.108.805689","volume":"2","author":"WA Ray","year":"2009","unstructured":"Ray WA, Varas-Lorenzo C, Chung CP et al (2009) Cardiovascular risks of non-steroidal anti-inflammatory drugs in patients following hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes 2:155\u2013163","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"4_CR114","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V69.1.180.180","volume":"69","author":"IA Reilly","year":"1987","unstructured":"Reilly IA, FitzGerald GA (1987) Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood 69:180\u2013186","journal-title":"Blood"},{"key":"4_CR115","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clpt.2006.05.004","volume":"80","author":"G Renda","year":"2006","unstructured":"Renda G, Tacconelli S, Capone ML et al (2006) Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Clin Pharmacol Ther 80:264\u2013274","journal-title":"Clin Pharmacol Ther"},{"key":"4_CR116","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archinte.162.10.1111","volume":"162","author":"E Rhame","year":"2002","unstructured":"Rhame E, Pilote L, LeLorier J (2002) Association between naproxen use and protection against acute myocardial infarction. Arch Intern Med 162:1111\u20131115","journal-title":"Arch Intern Med"},{"key":"4_CR117","first-page":"518","volume":"122","author":"B Rigas","year":"1993","unstructured":"Rigas B, Goldman IS, Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122:518\u2013523","journal-title":"J Lab Clin Med"},{"key":"4_CR118","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/STROKEAHA.107.508549","volume":"39","author":"CL Roumie","year":"2008","unstructured":"Roumie CL, Mitchel EFJ, Kaltenbach L, Arbogast PG, Gideon P, Griffin MR et al (2008) Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke. Stroke 39:2037\u20132045","journal-title":"Stroke"},{"key":"4_CR119","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2125.2002.01637.x","volume":"54","author":"R Schlienger","year":"2002","unstructured":"Schlienger R, Jick H, Meier C (2002) Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. Br J Clin Pharmacol 54:327\u2013332","journal-title":"Br J Clin Pharmacol"},{"key":"4_CR120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.plefa.2004.10.006","volume":"72","author":"MG Sciulli","year":"2005","unstructured":"Sciulli MG, Filabozzi P, Tacconelli S et al (2005) Platelet activation in patients with colorectal cancer. Prostaglandin Leukot Essent Fatty Acid 72:79\u201383","journal-title":"Prostaglandin Leukot Essent Fatty Acid"},{"key":"4_CR121","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.bjp.0705078","volume":"138","author":"MG Sciulli","year":"2003","unstructured":"Sciulli MG, Seta F, Tacconelli S et al (2003) Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells. Br J Pharmacol 138:634\u2013641","journal-title":"Br J Pharmacol"},{"key":"4_CR122","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.190.4.445","volume":"190","author":"SJ Shiff","year":"1999","unstructured":"Shiff SJ, Rigas B (1999) The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med 190:445\u2013450","journal-title":"J Exp Med"},{"key":"4_CR123","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"FE Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA 284:1247\u20131255","journal-title":"JAMA"},{"key":"4_CR124","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387\u2013437","journal-title":"Pharmacol Rev"},{"issue":"suppl III","key":"4_CR125","first-page":"85","volume":"64","author":"G Singh","year":"2005","unstructured":"Singh G, Mithal A, Triadafilopoulos G (2005) Both selective COX-2 inhibitors and non-selective NSAIDs increase the risk of acute myocardial infarction in patients with arthritis: selectivity is with the patient not the drug class. Ann Rheum Dis 64(suppl III):85\u201386","journal-title":"Ann Rheum Dis"},{"key":"4_CR126","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1186\/ar2047","volume":"8","author":"G Singh","year":"2006","unstructured":"Singh G, Wu O, Langhorne P, Madhok R (2006) Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther 8:R153\u2013R161","journal-title":"Arthritis Res Ther"},{"key":"4_CR127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/mc.20232","volume":"45","author":"FA Sinicrope","year":"2006","unstructured":"Sinicrope FA (2006) Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol Carcinog 45:447\u2013454","journal-title":"Mol Carcinog"},{"issue":"Suppl","key":"4_CR128","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","volume":"50","author":"EM Smyth","year":"2009","unstructured":"Smyth EM, Grosser T, Wang M, Yu Y et al (2009) Prostanoids in health and disease. J Lipid Res 50(Suppl):S423\u2013S428","journal-title":"J Lipid Res"},{"key":"4_CR129","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.162.10.1099","volume":"162","author":"D Solomon","year":"2002","unstructured":"Solomon D, Glynn R, Levin R (2002) Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med 162:1099\u20131104","journal-title":"Arch Intern Med"},{"key":"4_CR130","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.0000127578.21885.3E","volume":"109","author":"D Solomon","year":"2004","unstructured":"Solomon D, Schneeweiss S, Glynn R et al (2004) Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109:2068\u20132073","journal-title":"Circulation"},{"key":"4_CR131","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/art.21887","volume":"54","author":"DH Solomon","year":"2006","unstructured":"Solomon DH, Avorn J, Sturmer T et al (2006a) Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum 54:1378\u20131389","journal-title":"Arthritis Rheum"},{"key":"4_CR132","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","volume":"352","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA et al (2005) Adenoma prevention with celecoxib (APC) study investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071\u20131080","journal-title":"N Engl J Med"},{"key":"4_CR133","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.106.636746","volume":"114","author":"SD Solomon","year":"2006","unstructured":"Solomon SD, Pfeffer MA, McMurray JJ et al (2006b) Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation 114:1028\u20131035","journal-title":"Circulation"},{"key":"4_CR134","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","volume":"321","author":"Steering Committee of the Physicians\u2019 Health Study Research Group","year":"1989","unstructured":"Steering Committee of the Physicians\u2019 Health Study Research Group (1989) Final report on the aspirin component of the ongoing physicians\u2019 health study. Steering committee of the physicians\u2019 health study research group. N Engl J Med 321:129\u2013135","journal-title":"N Engl J Med"},{"key":"4_CR135","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","volume":"342","author":"G Steinbach","year":"2000","unstructured":"Steinbach G, Lynch PM, Phillips RK et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946\u20131952","journal-title":"N Engl J Med"},{"key":"4_CR136","first-page":"S57","volume":"14","author":"MCJM Sturkenboom","year":"2005","unstructured":"Sturkenboom MCJM, Dieleman J, Verhamme K et al (2005) Cardiovascular events during use of COX-2 selective and non-selective NSAIDs. Pharmacoepidemiol Drug Saf 14:S57","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4_CR137","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/art.22094","volume":"55","author":"S Suissa","year":"2006","unstructured":"Suissa S, Bernatsky S, Hudson M (2006) Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum 55:531\u2013536","journal-title":"Arthritis Rheum"},{"key":"4_CR138","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bmj.318.7186.759","volume":"318","author":"AG Thrift","year":"1999","unstructured":"Thrift AG, McNeil JJ, Forbes A et al (1999) Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study. BMJ 318:759\u2013764","journal-title":"BMJ"},{"key":"4_CR139","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/jnci\/82.8.650","volume":"82","author":"B Trock","year":"1990","unstructured":"Trock B, Lanza E, Greenwald P (1990) Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 82:650\u2013661","journal-title":"J Natl Cancer Inst"},{"key":"4_CR141","first-page":"250","volume":"31","author":"R Vane","year":"1971","unstructured":"Vane R (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 31:250\u2013260","journal-title":"Nat New Biol"},{"key":"4_CR142","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/pds.1815","volume":"18","author":"C Varas-Lorenzo","year":"2009","unstructured":"Varas-Lorenzo C, Castellsague J, Stang MR et al (2009) The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada. Pharmacoepidemiol Drug Saf 18:1016\u20131025","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4_CR143","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pds.1192","volume":"15","author":"P Velentgas","year":"2006","unstructured":"Velentgas P, West W, Cannuscio CC et al (2006) Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications. Pharmacoepidemiol Drug Saf 15:641\u2013652","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4_CR144","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMoa055222","volume":"354","author":"J Wactawski-Wende","year":"2006","unstructured":"Wactawski-Wende J, Kotchen JM, Anderson GL et al (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354:684\u2013696","journal-title":"N Engl J Med"},{"key":"4_CR145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN (2010a) Eicosanoids and cancer. Nat Rev Cancer 10:181\u2013193","journal-title":"Nat Rev Cancer"},{"key":"4_CR146","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","volume":"29","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN (2010b) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29:781\u2013788","journal-title":"Oncogene"},{"key":"4_CR147","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archinte.162.10.1105","volume":"162","author":"D Watson","year":"2002","unstructured":"Watson D, Rhodes T, Holmes R (2002) Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med 162:1105\u20131110","journal-title":"Arch Intern Med"},{"key":"4_CR148","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jnci\/djg040","volume":"95","author":"HK Weir","year":"2003","unstructured":"Weir HK, Thun MJ, Hankey BF et al (2003) Annual report to the nation on the status of cancer, 1975\u20132000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95:1276\u20131299","journal-title":"J Natl Cancer Inst"},{"key":"4_CR149","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1056\/NEJM199012133232404","volume":"323","author":"WC Willett","year":"1990","unstructured":"Willett WC, Stampfer MJ, Colditz GA et al (1990) Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323:1664\u20131672","journal-title":"N Engl J Med"},{"key":"4_CR150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnci\/94.6.437","volume":"94","author":"K Wu","year":"2002","unstructured":"Wu K, Willett WC, Fuchs CS et al (2002) Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 94:437\u2013446","journal-title":"J Natl Cancer Inst"}],"container-title":["Recent Results in Cancer Research","Prospects for Chemoprevention of Colorectal Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-30331-9_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T05:30:41Z","timestamp":1687671041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-30331-9_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"ISBN":["9783642303302","9783642303319"],"references-count":149,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-30331-9_4","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-642-30331-9","asserted-by":"object"}]},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,15]]},"assertion":[{"value":"15 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}